TEVA

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is slated to announce second quarter 2015 earnings results on Thursday, July 30, before market open. The …

Youku Tudou Inc (ADR) (NYSE:YOKU) shares slipped more than -6% in pre-market trading down to $18.77 after Chinese shares fell more than 8%.

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced the launch of generic Axert® (almotriptan malate) tablets, 6.25 mg and 12.

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Xenon Pharmaceuticals Inc. reported top line results from the double-blind, placebo-controlled Phase 2b study designed to evaluate the safety …

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Active Biotech announced that the patient enrollment for the pivotal Phase III CONCERTO trial has been finalized, as well …

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced that it has completed the purchase of 4.61 percent of all outstanding shares of Mylan N.

Maxim Group analyst Jason Kolbert weighed in today with some commentary on Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) after a U.S.

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Microchips Biotech, Inc. today announced that they have entered into a partnership under which the companies will explore innovative …

Maxim analysts Jason Kolbert and Jason Mccarthy weighed in today on the Israeli pharmaceutical giant Teva Pharmaceutical Industries Ltd (NYSE:TEVA), California based gene therapy company Avalanche Biotechnologies Inc (NASDAQ:AAVL), and gene therapy …

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced positive top-line results from the pivotal clinical study Aim to Reduce Movements in TardiveDyskinesia (ARM-TD) designed to evaluate the efficacy of …